The CBIRC, the Jilin Provincial People's Government, the State Food and Drug Administration, and other four ministries and commissions have released a compensation plan to be set up by Changchun Changsheng Biotech Company that would make payouts to victims of a human rabies vaccine safety scandal at the company.